Published in The Journal of Health, Population, and Nutrition, this study assesses the importance of enterotoxigenic Escherichia coli (ETEC) as a diarrhoeal agent in developing countries.

This study, published in the Journal of Tropical Medicine and Hygiene, evaluated the feasibility of antibody markers as indicators of infections with water-borne pathogens in order to determine the epidemiology of water-borne diarrheal …

This article, published in the Expert Review of Vaccines, describes the status of vaccines under development to address enterotoxigenic Escherichia coli (ETEC), which have been designed to stimulate local intestinal immunity and are delivered either …

This fact sheet describes how PATH developed a low-cost and straightforward technology for protecting aluminum-adjuvanted liquid vaccines from the irreversible damage that results from freezing. Many current vaccines of importance to global …

This fact sheet provides an overview of PATH's work, including vaccine development and introduction, in protecting children from diarrheal disease.

These pre-formatted PubMed searches will retrieve journal citations and available abstracts that address relevant issues related to ETEC and Shigella. Documents may be ordered through Loansome Doc if you have established an agreement with a …

Published in the Journal of Evalution in Clinical Practice, this study was part of a research effort to identify and quantify factors related to the cost-effectiveness of a vaccine acquisition strategy to reduce the burden of infectious diarrhea on …

This article, published in Annals of the Rheumatic Diseases, describes the epidemiology and clinical spectrum of reactive arthritis (ReA) following culture-confirmed infection with bacterial enteric pathogens in a population-based study in …

The burden of dysentery due to shigellosis among children in the developing world is a major concern, but no licensed vaccine is available. This review article, published in Expert Review of Vaccines, provides an update on Shigella vaccine …

This article, published in Clinical and Vaccine Immunology, reports on a study which found that a lower dose than used previously of the human challenge model for enterotoxigenic Escherichia coli diarrhea using strain H10407 is sufficient for …

Published in the journal Vaccine, the article reviews the state of the art in vaccine research and development against human viral and bacterial enteric infections of public health importance.

To assist donors in understanding the potential of different research avenues to contribute to reducing the burden of disease and disability, the Child Health and Nutrition Research Initiative (CHNRI) of the Global Forum for Health Research recently …

This web page provides information on shigellosis disease burden and vaccine development, as well as relevant links.

This document analyzes research and development activities for vaccines against infectious diseases of public health importance. Disease groups covered include diarrheal disease, sexually transmitted diseases, respiratory infections, bacterial …

These documents provide the latest stability data for commonly used vaccines and current research on vaccine formulations and platform technologies. Data are sorted by vaccine in a table format in both documents.

This review, published in The Journal of Travel Medicine, focuses on the strategies behind development and potential use of currently available vaccines and vaccine candidates against enterotoxigenic Escherichia coli (ETEC) infection. As …

This website provides information about the work of PATH’s Vaccine Development Global Program to improve the health of people, especially infants and children living in low-income countries, by accelerating the development of vaccines …

This quarterly e-newsletter provides an update on PATH’s efforts to accelerate the development of innovative, safe, effective, and affordable vaccines against the leading causes of childhood deaths in developing-world populations, pneumonia …

This fact sheet provides an overview of PATH's work in developing fast-dissolving tablet vaccine formulations that are manufactured using a standard lyophilization process. The small tablets are packaged in unit-dose blisters offering an …